FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Rosiglitasone Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

GlaxoSmithKline (New 04/23/2021)

Company Contact Information:
888-825-5249

Presentation Posting Date Related Information
2 mg (NDC 0173-0861-18) 04/23/2021 This product discontinuation is a business-related decision. GSK has ceased distribution of this product.
4 mg (NDC 0173-0863-13) 04/23/2021 This product discontinuation is a business-related decision. GSK has ceased distribution of this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English